Fusion Fuel Green PLC Announces Two Engineering Contracts Totaling Approximately $1.37 Million for Residential Developments in Dubai, United Arab Emirates

(NASDAQ:HTOO), Dublin, Ireland, Dec. 03, 2025 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a leading provider of full-service energy engineering, advisory, and utility solutions, today announced that Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), a full-service industrial gas solution provider in which the Company indirectly […]

Digi Power X Implementing First B200 GPU Cluster in Alabama with Plans to Begin Data Processing in Q1 2026

(TSX-V:DGX),(NASDAQ:DGXX), This news release constitutes a “designated news release” for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated May 15, 2025. MIAMI, Dec. 03, 2025 (GLOBE NEWSWIRE) — Digi Power X Inc. (“Digi Power X” or the “Company“) (Nasdaq: DGXX /

Relmada Therapeutics Announces Presentation of NDV-01 Phase 2 Data at the Society for Urologic Oncology

(NASDAQ:RLMD), Poster highlights 6-month follow-up data from the ongoing Phase 2 trial of NDV-01 in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety Relmada plans to advance NDV-01, a sustained release intravesical formulation of gemcitabine/docetaxel (Gem/Doce), into Phase 3 studies in two indications in H1 2026 Company is focused on high-risk NMIBC and intermediate-risk

Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

(NASDAQ:CGTX), PURCHASE, N.Y., Dec. 03, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that its expanded access program has reached full enrollment. Each of the individuals enrolled in the program are being treated with 100 mg of oral zervimesine daily

Brixton Metals Closes Tranche 1 Of Its Private Placement

(TSX-V:BBB),(OTC US:BBBXF),(Other OTC:BBBXF), Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton“) is pleased to announce that it completed on December 2, 2025, the first tranche of a non-brokered

Habit Burger & Grill Celebrates Hope Mills Restaurant Launch

New Fayetteville area Habit to Open on December 10Hold Pre-Opening VIP Events on December 6, 8-9 IRVINE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — Habit Burger & Grill, the California-based restaurant company renowned for its award-winning Charburgers grilled over an open flame, signature sandwiches, fresh salads, and more, announces today the opening of their second

Bread Financial to Participate in the Goldman Sachs 2025 Financial Services Conference

(NYSE:BFH), COLUMBUS, Ohio, Dec. 03, 2025 (GLOBE NEWSWIRE) — Bread Financial(R) Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions today announced the company's participation in the Goldman Sachs 2025 Financial Services Conference on Wednesday, December 10. Bread Financial President and Chief Executive Officer Ralph Andretta,

BTQ Technologies Announces Research Coverage from Leading Digital Asset Research Firm Delphi Digital on Bitcoin Quantum, the Quantum-Safe Bitcoin Network Developed by BTQ

— Delphi Digital research coverage:Delphi Digital, a leading independent digital asset research firm, has published an in-depth report on BTQ Technologies and Bitcoin Quantum, validating BTQ's role in addressing the emerging quantum threat to Bitcoin and the broader crypto ecosystem. — Bitcoin Quantum as a “quantum canary” network: The report highlights Bitcoin Quantum as a

DIAMONDROCK HOSPITALITY DECLARES FOURTH QUARTER DIVIDEND

Common Dividends for 2025 Total $0.36 Per Share, a 12.5% Increase over 2024 DiamondRock Hospitality Company (the “Company” or “DiamondRock”) (Nasdaq: DRH) announced that its Board of Directors has declared a fourth quarter dividend of $0.12 per common share, which includes the Company's regular quarterly dividend of $0.08 per common share, along with a stub

ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

ZYNLONTA® in combination with glofitamab (COLUMVI®) demonstrated an 89.8% ORR and 77.6% CR across the 49 efficacy-evaluable patients with a minimum of 6 months of follow-up Combination continues to be generally well-tolerated with a manageable safety profile LOTIS-7 trial is on track for complete patient enrollment in 1H 2026; plan to share full data at

Scroll to Top